Ascendis Pharma AS

Stock Chart, Company Information, and Scan Results

$227.50(as of Mar 11, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ascendis Pharma AS Company Information, Fundamentals, and Technical Indicators

Stock Price$227.50
Ticker SymbolASND
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees1,189
CountyUSA
Market Cap$14,766.3M
EBIDTA-131.4M
10-Day Moving Average237.11
P/E Ratio-61.32
20-Day Moving Average231.52
Forward P/E Ratio45.66
50-Day Moving Average223.63
Earnings per Share-4.33
200-Day Moving Average199.93
Profit Margin-13.56%
RSI47.20
Shares Outstanding61.4M
ATR10.26
52-Week High248.60
Volume881,016
52-Week Low124.06
Most Recent Support Level233.00
Book Value-162.8M
Most Recent Resistance Level245.63
P/B Ratio-85.80
Upper Keltner254.60
P/S Ratio19.45
Lower Keltner208.44
Debt-to-Equity Ratio254.60
Next Earnings Date04/30/2026
Cash Surplus-453.2M
Next Ex-Dividend DateUnknown

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.

Ascendis Pharma AS In Our Stock Scanner

As of Mar 12, 2026
example chart graphic
Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.